Equillium, Inc. (EQ): Nasdaq/NYSE listing notice — Equillium enters new ATM equity facility with Jefferies; gets Nasdaq extension to April 2024

October 3, 2023, in connection with the transfer of the listing of the Company’s common stock from the Nasdaq Global Market to the Nasdaq Capital Market, the Company was granted an additional 180-day grace period, or until April 1, 2024, to regain compliance with the Minimum Bid Price Requirement. The Company’s failure to regain compliance during this period could result in delisting. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements, including such actions as a reverse stock split.

On October 5, 2023, Equillium, Inc. (the " Company ") entered into an Open Market Sale Agreement SM (the " Sale Agreement ") with Jefferies LLC (" Jefferies "), pursuant to which the Company may, from time to time, offer and sell shares of the Company’s common stock, par value $0.0001 per share (the " Shares "), through Jefferies, as the Company’s sales agent and/or principal.

On October 5, 2023, the Company and Jefferies terminated that certain Open Market Sale Agreement SM (the " Prior Agreement ") that the Company entered into with Jefferies on July 14, 2020.